Elutia (ELUT) FCF Margin Growth (1y) (2020 - 2026)
Elutia (ELUT) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -473.00 |
| 10 | Elutia | 39.84 Mn | 19.94 Mn | 1.45 Mn | -4,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,515.00 |
| Dec 31, 2025 | -34,599.00 |
| Sep 30, 2025 | 229.00 |
| Jun 30, 2025 | -6,422.00 |
| Mar 31, 2025 | -27,069.00 |
| Dec 31, 2024 | -28,371.00 |
| Sep 30, 2024 | -2,389.00 |
| Jun 30, 2024 | -2,987.00 |
| Mar 31, 2024 | 4,399.00 |
| Dec 31, 2023 | -7,323.00 |
| Sep 30, 2023 | 1,166.00 |
| Jun 30, 2023 | 4,773.00 |
| Mar 31, 2023 | -1,943.00 |
| Dec 31, 2022 | -2,262.00 |
| Sep 30, 2022 | -6,847.00 |
| Jun 30, 2022 | -7,926.00 |
| Mar 31, 2022 | -2,306.00 |
| Dec 31, 2021 | -1,505.00 |
| Sep 30, 2021 | -1,368.00 |
| Jun 30, 2021 | 3,941.00 |